TGI
SCMP

Tradewinds Global Investors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Tradewinds Global Investors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,362
Closed -$256K – 162
2016
Q2 		$256K Buy
+23,362
New +$261K 0.02% 130

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Tradewinds Global Investors's SCMP Position: Q3 2016 in Review

Tradewinds Global Investors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 23,362 shares — an estimated $256K sold.

Tradewinds Global Investors first reported a position in SCMP in Q2 2016 and held it in 1 quarter. The position peaked at $256K in Q2 2016. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Tradewinds Global Investors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Tradewinds Global Investors sold 23,362 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $256K.
  • Tradewinds Global Investors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 1 quarter.
  • Tradewinds Global Investors's Sucampo Pharmaceuticals, Inc. position peaked at $256K in Q2 2016.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Tradewinds Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.